Medicare Enrolled

Dr. Michael Dyal, M.D.

Cardiovascular Disease · Miami, FL
Speaking/Promotional
1201 NW 16TH ST STE C1008, Miami, FL 33125
3055757000
In practice since 2008 (17 years)
NPI: 1669649539 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dyal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dyal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dyal

Dr. Michael Dyal is a cardiovascular disease specialist in Miami, FL, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Dyal received a total of $129,393 from 20 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dyal is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $129,393 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 109963 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$129,393
Total received (2018-2024)
Avg $18,485/year across 7 years
Top 4% in FL for cardiovascular disease
20
Companies
181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65,413 (50.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$54,690 (42.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,290 (7.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$56,038
2023
$39,853
2022
$19,858
2021
$7,817
2020
$3,577
2019
$796
2018
$1,454

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$57,562
Philips Electronics North America Corporation
$46,194
Philips North America LLC
$9,719
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9,500
BOSTON SCIENTIFIC CORPORATION
$2,717
Boston Scientific Corporation
$764
Medtronic Vascular, Inc.
$478
Impulse Dynamics (USA) Inc.
$436
BIOTRONIK INC.
$425
Inari Medical, Inc.
$420
Edwards Lifesciences Corporation
$316
Medtronic, Inc.
$259
ABIOMED
$177
LivaNova USA, Inc.
$148
Penumbra, Inc.
$100
Alnylam Pharmaceuticals Inc.
$89
LANTHEUS MEDICAL IMAGING, INC.
$25
Shockwave Medical, Inc
$23
Chiesi USA, Inc.
$23
Silk Road Medical, Inc.
$18
Top 3 companies account for 87.7% of total payments
Associated products mentioned in payments ›
(1399) MRI Equip Undiv · (6361) Core Mobile · (7881) US Und · (7881) Ultrasound Und · (9266) ELCA · (9520) IGT Devices Und · (BH4) IGT Devices Undivided · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · AMVUTTRA · AVEIR · AVVIGO Guidance System · Allure Quadra RF CRT Pacemaker · COREVALVE EVOLUT R · CROSSBOSS · CRT-Ds · CoreValve Evolut · DEFINITY · ENROUTE Transcarotid Neuroprotection System · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FLOWTRIEVER CATHETER · Fortify Assura · GENERAL - STRUCTURAL HEART · GUIDEZILLA · Impella · Indigo System · JETI ALL IN ONE NON-STERILE KIT · KENGREAL · LifeVest · MITRACLIP · Memo4D · Mitra Clip system · ONYX FRONTIER · OPTIMIZER · Occluders · Optimizer · Resolute · S · Sentinel · TandemLife · Trifecta GT Tissue Heart Valve · Valve Repair Flexible Rings and Bands · Vascular Lithotripsy · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in FL.

Looking for a cardiovascular disease specialist in Miami?
Compare cardiologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
398
Per 100K population
14.8
County median income
$68,694
Nearest hospital
MIAMI VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dyal is a cardiovascular disease specialist, with speaking/promotional industry engagement in the top 4% of FL peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Dyal receive payments from pharmaceutical companies?
Yes. Dr. Dyal received a total of $129,393 from 20 companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Dyal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →